How medicare part D benefit phases affect adherence with evidence-based medications following acute myocardial infarction

Health Services Research

Volumn 48, Issue 6 PART1, 2013, Pages 1960-1977

  Stuart, Bruce ^a   Davidoff, Amy ^b   Erten, Mujde ^c   Gottlieb, Stephen S ^d   Dai, Mingliang ^a   Shaffer, Thomas ^e   Zuckerman, Ilene H ^a   Simoni Wastila, Linda ^a   Bryant Comstock, Lynda ^f   Shenolikar, Rahul ^f  

^a UNIVERSITY OF MARYLAND   (United States)

^b AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e University of Maryland Baltimore ^*  (United States)

^f GLAXOSMITHKLINE   (United States)

Author keywords

AMI; Benefit design; Evidence based drugs; Medicare Part D

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; CARDIOVASCULAR AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG COST; DRUG UTILIZATION; EVIDENCE BASED PRACTICE; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICARE; MEDICATION COMPLIANCE; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; VERY ELDERLY; ACUTE DISEASE; AGE; AMI; BENEFIT DESIGN; DEMOGRAPHY; ECONOMICS; EVIDENCE-BASED DRUGS; HEART INFARCTION; INSURANCE; SEX DIFFERENCE; SOCIOECONOMICS; STATISTICS; UNITED STATES; MYOCARDIAL INFARCTION; STATISTICS AND NUMERICAL DATA;

AMI; BENEFIT DESIGN; EVIDENCE-BASED DRUGS; MEDICARE PART D;

ACUTE DISEASE; AGE FACTORS; AGED; AGED, 80 AND OVER; CARDIOVASCULAR AGENTS; DRUG UTILIZATION; EVIDENCE-BASED PRACTICE; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; MALE; MEDICARE PART D; MEDICATION ADHERENCE; MYOCARDIAL INFARCTION; RESIDENCE CHARACTERISTICS; SEX FACTORS; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84893005294     PISSN: 00179124     EISSN: 14756773     Source Type: Journal    
DOI: 10.1111/1475-6773.12073     Document Type: Article

References (17)

1. Anderson, J. L., C. D. Adams, E. M. Antman, et al. 2007. " ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines." Journal of the American College of Cardiology 50: e1-157.
2. Antman, E. M., M. Hand, P. W. Armstrong, et al. 2008. " 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines." Journal of the American College of Cardiology 51: 210-47.
3. Choudhry, N., S. Setoguchi, R. Levin, W. Winkelmayer, and, W. Shrank,. 2008. " Trends in Adherence to Secondary Prevention Medications in Elderly Post-Myocardial Infarction Patients." Pharmacoepidemiology and Drug Safety 17: 1189-96.
4. Choudhry, N., J. Avorn, R. Glynn, E. Antman, S. Schneeweise, et al. 2011. " Full Coverage for Preventive Medications after Myocardial Infarction." New England Journal of Medicine 365: 2088-97.
5. Ellis, R., 1986. " Rational Behavior in the Presence of Coverage Ceilings and Deductibles." Rand Journal of Economics 17 (2): 158-75.
6. Gu, Q., F. Zeng, B. V. Patel, and, L. Tripoli,. 2010. " Part D Coverage Gap and Adherence to Diabetes Medications." American Journal of Managed Care 16 (12): 911-8.
7. Hales, J. W., and, S. George,. 2010. " How the Doughnut Hole Affects Prescription Fulfillment Decisions Involving Cardiovascular Medications for Medicare Part D Enrollees." Managed Care December: 36-44.
8. Hoadley, J., E. Hargrave, C. Juliette, and, L. Summer,. 2011. Understanding the Effects of the Medicare Part D Coverage Gap in 2008 and 2009: Cost and Consequences Prior to Improvements in Coverage Established by the 2010 Health Reform Law. Washington, DC: Kaiser Family Foundation.
9. Lau, D. T., B. A. Briesacher, D. R. Touchette, J. Stubbings, and, J. H. Ng,. 2011. " Medicare Part D and Quality of Prescription Medication Use in Older Adults." Drugs and Aging 28 (10): 797-807.
10. Leuven, E., and, B. Sianesi,. 2003. " PSMATCH2: Stata Module to Perform Full Mahalanobis and Propensity Score Matching, Common Support Graphing, and Covariate Imbalance Testing " [accessed on December 13, 2012]. Available at http://ideas.repec.org/c/boc/bocode/s432001.html
11. Medical Economics. 2009. Red Book: Pharmacy's Fundamental Reference. New York: Medical Economics Company, 2009 Edition.
12. Osterberg, L., and, T. Blaschle,. 2005. " Adherence to Medication." New England Journal of Medicine 353 (%): 487-97.
13. Pedan, A., J. Lu, and, L. Varasteh,. 2009. " Assessment of Drug Consumption Patterns for Medicare Part D Patients." American Journal of Managed Care 15 (5): 323-7.
14. Polinski, J. M., W. H. Shrank, H. A. Huskamp, R. J. Glynn, J. N. Liberman, and, S. Schneeweiss,. 2011. " Changes in Drug Utilization during a Gap in Insurance Coverage: An Examination of the Medicare Part D Coverage Gap." PLoS Medicine 8 (8): e1001075.
15. Yin, W., A. Basu, A. Zhang, et al. 2008. " The Effect of the Medicare Part D Prescription Benefit on Drug Utilization and Expenditures." Annals of Internal Medicine 148 (3): 169-77.
16. Zhang, J., W. Yin, S. Sun, et al. 2008. " The Impact of the Medicare Part D Prescription Benefit on Generic Drug Use." Journal of General Internal Medicine 23 (10): 1673-8.
17. Zhang, J., W. Yin, S. Sun, et al. 2009. " The Effect of Medicare Part D on Drug and Medical Spending." New England Journal of Medicine 361 (1): 52-61.